Difference between revisions of "Drug toxicity"

Jump to navigation Jump to search
56 bytes added ,  15:15, 5 September 2014
no edit summary
Line 3: Line 3:
This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.
This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.


=Liver drug toxicity=
*[[Drug-induced liver disease]].
=Luminal gastrointestinal pathology=
==Sodium polystyrene sulfonate==
==Sodium polystyrene sulfonate==
:[[AKA]] ''Kayexalate'' (trade name).
:[[AKA]] ''Kayexalate'' (trade name).
Line 20: Line 24:
{{Main|Proton pump inhibitor effect}}
{{Main|Proton pump inhibitor effect}}


==See also==
=See also=
*[[Drug-induced liver disease]].
*[[Minocycline associated thyroid pigmentation]].
*[[Minocycline associated thyroid pigmentation]].
*[[Spironolactone bodies]].
*[[Spironolactone bodies]].


==References==
=References=
{{Reflist|1}}
{{Reflist|1}}


[[Category:Stuff]]
[[Category:Stuff]]
48,790

edits

Navigation menu